GlassScriptPhysician profile
Paul Gulsharan Singh
NPI 1043221328
$11,733.24
in general payments reported to CMS, 2019-2025
45 companies · $1,902 in 2025
The $1,902 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $3,070 · 2021: $946 · 2022: $770 · 2023: $2,790 · 2024: $1,770 · 2025: $1,902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,757 · Travel and Lodging: $1,684 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,756.91 |
| Travel and Lodging | $1,684.24 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $2,600.00 | 2020 | |
| Imperative Care, INC | $1,684.24 | 2023 | Zoom 88-T Large Distal Platform |
| Biotronik Nro, INC. | $1,582.36 | 2023-2025 | Prospera, Biotronik |
| Boston Scientific Corporation | $1,269.36 | 2020-2025 | Wavewriter Alpha Prime 16, General - Therapies |
| Medtronic, INC. | $705.53 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Scilex Pharmaceuticals INC. | $544.18 | 2020-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $409.65 | 2019-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $390.86 | 2019-2025 | Eterna, Proclaim |
| Forte Bio-Pharma LLC | $289.90 | 2019-2025 | Prolate, Nalocet, Tanlor |
| New World Medical,INC. | $177.97 | 2023 | |
| Pfizer INC. | $175.26 | 2019-2021 | |
| Radius Health, INC. | $172.62 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $163.01 | 2024-2025 | |
| Averitas Pharma INC. | $155.36 | 2023-2025 | Qutenza |
| Si-Bone, INC. | $148.35 | 2019-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.